Related Experiment Videos

[Serum cardiac troponin-T in coronary artery bypass graft and mitral valve replacement]

K Hara1, J Koh, K Kohno

  • 1Department of Anesthesia, Kure National Hospital.

Masui. the Japanese Journal of Anesthesiology
|October 1, 1995
PubMed

Insights

Serum troponin-T levels indicate myocardial injury occurs during heart surgery. Coronary artery bypass graft (CABG) surgery resulted in more severe myocardial injury compared to mitral valve replacement (MVR).

Area of Science:

  • Cardiology
  • Biochemistry

Context:

  • Cardiac surgery, including coronary artery bypass graft (CABG) and mitral valve replacement (MVR), carries a risk of perioperative myocardial injury.
  • Accurate assessment of myocardial injury is crucial for patient outcomes.

Purpose:

  • To evaluate perioperative myocardial injury using serum cardiac troponin-T levels in patients undergoing CABG and MVR.
  • To compare the extent of myocardial injury between CABG and MVR procedures.

Summary:

  • Serum cardiac troponin-T was measured preoperatively, postoperatively, and on the first postoperative day in 12 CABG and 9 MVR patients.
  • Elevated postoperative troponin-T levels were observed in both groups, with significantly higher levels in the CABG group on the first postoperative day (6.05 +/- 4.16 ng.ml-1) compared to the MVR group (2.57 +/- 2.12 ng.ml-1).
  • These findings suggest that myocardial injury occurs during heart surgery, and the severity is greater following CABG than MVR.

Impact:

  • This study highlights the utility of cardiac troponin-T as a biomarker for detecting perioperative myocardial injury in cardiac surgery.
  • The results indicate that CABG procedures may lead to a more significant degree of myocardial injury than MVR.
  • Understanding these differences can inform surgical strategies and patient management to mitigate cardiac damage.

Related Concept Videos